市場調査レポート

商品コード

1783536

メバロノラクトンの市場レポート：2031年までの動向、予測、競合分析

Mevalonolactone Market Report: Trends, Forecast and Competitive Analysis to 2031

出版日: 2025年07月31日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日

カスタマイズ可能

適宜更新あり

価格

PDF (Single User License)

USD 3,850 574,766円

レポートPDFを購入者の1名のみがご利用頂けるライセンスです。PDFファイルは、DRM (デジタル著作権管理システム) 付きです。PDF内のテキスト等のコピー＆ペーストは可能ですが、編集はできません。PDF内コンテンツは印刷可能ですが、印刷したもののご利用は、PDFのご利用範囲に準拠します。

PDF (2 Users License)

USD 4,650 694,198円

レポートPDFを同じ事業所内の2名までがご利用頂けるライセンスです。PDFファイルは、DRM (デジタル著作権管理システム) 付きです。PDF内のテキスト等のコピー＆ペーストは可能ですが、編集はできません。PDF内コンテンツは印刷可能ですが、印刷したもののご利用は、PDFのご利用範囲に準拠します。

PDF (5 Users License)

USD 5,350 798,701円

レポートPDFを同じ事業所内の5名までがご利用頂けるライセンスです。PDFファイルは、DRM (デジタル著作権管理システム) 付きです。PDF内のテキスト等のコピー＆ペーストは可能ですが、編集はできません。PDF内コンテンツは印刷可能ですが、印刷したもののご利用は、PDFのご利用範囲に準拠します。

PDF (Corporate License)

USD 7,050 1,052,494円

レポートPDFを企業内すべての方が使用頂けるライセンスです。ご利用人数の制限はありませんが、同一国内にある事業所のみとなり、海外支店などは含まれません。PDFファイルは、DRM (デジタル著作権管理システム) 付きです。PDF内のテキスト等のコピー＆ペーストは可能ですが、編集は出来ません。PDF内コンテンツの印刷は可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=149.29円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のメバロノラクトン市場の将来は、医薬品、化粧品・パーソナルケア製品、飲食品、バイオテクノロジー、農薬市場に機会がありそうです。世界のメバロノラクトン市場は、2025年から2031年にかけてCAGR 9.5％で成長すると予想されます。この市場の主な促進要因は、コレステロール低下剤に対する需要の増加、代謝性疾患治療に対するニーズの高まり、心血管の健康に対する関心の高まりです。

Lucintel社は、製品タイプ別では純粋メバロノラクトンが予測期間中に最も高い成長を遂げると予測しています。
用途別では医薬品が最も高い成長が見込まれます。
地域別では、APACが予測期間中に最も高い成長が見込まれています。

150ページ以上の包括的なレポートで、ビジネス上の意思決定に役立つ貴重な洞察を提供しています。いくつかの洞察を含むサンプル図を以下に示します。

メバロノラクトン市場の新たな動向

メバロノラクトン市場は、バイオテクノロジーの進歩や持続可能で高純度な化学物質への需要の高まりの影響を受け、その成長と将来の軌道を決定づける様々な新たな動向に見舞われています。

バイオテクノロジーによる生産プロセス：主要動向は、メバロノラクトン合成におけるバイオテクノロジー経路の調査と利用の拡大です。これには、遺伝子組み換え微生物を用いたマロン酸の生合成と、それに続くメバロノラクトンのラクトン化が含まれます。このようなプロセスは、従来の化学合成に比べ、より環境に優しく持続可能な製造が期待されています。
高純度メバロノラクトンの需要：メバロノラクトンは、特に高感度な医薬化学品の合成中間体としての役割や、高度な研究目的のために、非常に高い純度レベルのメバロノラクトンに対するニーズが高まっています。こうした厳しい品質ニーズを満たすためには、精製・分析技術の向上が不可欠です。
栄養補助食品用途への拡大：スタチン製造における確立された地位に加え、メバロノラクトンとその誘導体は、栄養補助食品への応用も検討されています。メバロノラクトンから生産されるイソプレノイドが健康にもたらす潜在的な利益に関する研究がこの動向に拍車をかけており、新たな市場セグメントを提供する可能性があります。
新規メバロノラクトン誘導体の開発：メバロノラクトンの化学修飾により、医薬品、農薬、材料科学産業における特定の用途向けに特性をカスタマイズした新規誘導体が開発されています。この動向は、独創的な化学合成によってメバロネート・プラットフォームの応用範囲を広げることに集中しています。
持続可能でグリーンな生産への注力：持続可能性に対する世界の関心の高まりは、メバロノラクトンのより環境にやさしく持続可能な生産プロセスを構築する動向に圧力をかけています。これには、廃棄物の発生を最小限に抑え、再生可能な原材料を使用し、製造工程で有害な化学物質の使用を避けることが含まれます。

こうした新たな動向は、生産革新の促進、製品品質の向上、応用分野の拡大、製造工程における環境配慮の促進によって、メバロノラクトン市場を一挙に変貌させつつあります。

メバロノラクトン市場の最近の動向

メバロノラクトン市場の最近の動向は、生産の効率化、製品品質の向上、この貴重な化学中間体の新たな用途の特定に向けた継続的な活動を強調しています。

発酵プロセスの最適化：マロン酸のバイオテクノロジー的製造のための発酵プロセスの最適化において重要な進展が達成され、メバロノラクトンの収率の向上と製造コストの削減が実現されています。
高度精製技術の開発：高度なクロマトグラフィーや膜分離技術を含む高度な精製技術は、繊細な用途に適したメバロノラクトンの純度を高めるために使用されています。
キラルなメバロノラクトン誘導体の合成：キラルなメバロノラクトン誘導体の合成に効果的な手法を用いることで、エナンチオマー的に純粋な医薬品中間体の製造への応用が進んでいます。
メバロノラクトンベースの農薬開発：メバロノラクトン誘導体を植物成長調節剤や殺虫剤のような新しい農薬として使用する可能性を初期調査しています。
戦略的パートナーシップの形成：化学メーカー、バイオテクノロジー企業、研究機関のパートナーシップが、メバロノラクトンの製造と用途開発の技術革新を推進しています。

こうした重要な開発は、メバロノラクトンの生産をより持続可能で経済的なものにし、需要の高い用途向けの品質を向上させ、さまざまな産業部門にわたる新たな用途の可能性を調査することで、メバロノラクトン市場に影響を与えています。

マクロ経済動向（2019～2024年）と予測（2025～2031年）
世界のメバロノラクトン市場動向（2019～2024年）と予測（2025～2031年）
世界のメバロノラクトン市場：製品タイプ別
- 純粋メバロノラクトン：動向と予測（2019～2031年）
- メバロノラクトンブレンド：動向と予測（2019～2031年）
- メバロノラクトン誘導体：動向と予測（2019～2031年）
世界のメバロノラクトン市場：用途別
- 医薬品：動向と予測（2019～2031年）
- 化粧品・パーソナルケア製品：動向と予測（2019～2031年）
- 飲食品：動向と予測（2019～2031年）
- バイオテクノロジー：動向と予測（2019～2031年）
- 農薬：動向と予測（2019～2031年）
- その他：動向と予測（2019～2031年）
世界のメバロノラクトン市場：最終用途別
- 医薬品：動向と予測（2019～2031年）
- 化学メーカー：動向と予測（2019～2031年）
- 食品加工：動向と予測（2019～2031年）
- バイオテクノロジー企業：動向と予測（2019～2031年）
- 化粧品メーカー：動向と予測（2019～2031年）
- その他：動向と予測（2019～2031年）

第4章 2019年から2031年までの地域別市場動向と予測分析

世界のメバロノラクトン市場：地域別
北米のメバロノラクトン市場
欧州のメバロノラクトン市場
アジア太平洋のメバロノラクトン市場
その他地域のメバロノラクトン市場

第5章競合分析

製品ポートフォリオ分析
運用統合
ポーターのファイブフォース分析
- 競争企業間の敵対関係
- 買い手の交渉力
- 供給企業の交渉力
- 代替品の脅威
- 新規参入業者の脅威

第6章成長機会と戦略分析

成長機会分析
- 世界のメバロノラクトン市場における成長機会：製品タイプ別
- 世界のメバロノラクトン市場における成長機会：用途別
- 世界のメバロノラクトン市場における成長機会：最終用途別
- 世界のメバロノラクトン市場における成長機会：地域別
世界のメバロノラクトン市場における新たな動向
戦略分析
- 新製品開発
- 世界のメバロノラクトン市場の生産能力拡大
- 世界のメバロノラクトン市場における合併、買収、合弁事業
- 認証とライセンシング

第7章主要企業の企業プロファイル

ADEKA
Carbosynth Product
TLC Pharmaceutical
Rinner Group
Tocris Bioscience

図表

List of Figures

Figure 2.1: Classification of the Global Mevalonolactone Market
Figure 2.2: Supply Chain of the Global Mevalonolactone Market
Figure 3.1: Trends of the Global GDP Growth Rate
Figure 3.2: Trends of the Global Population Growth Rate
Figure 3.3: Trends of the Global Inflation Rate
Figure 3.4: Trends of the Global Unemployment Rate
Figure 3.5: Trends of the Regional GDP Growth Rate
Figure 3.6: Trends of the Regional Population Growth Rate
Figure 3.7: Trends of the Regional Inflation Rate
Figure 3.8: Trends of the Regional Unemployment Rate
Figure 3.9: Trends of Regional Per Capita Income
Figure 3.10: Forecast for the Global GDP Growth Rate
Figure 3.11: Forecast for the Global Population Growth Rate
Figure 3.12: Forecast for the Global Inflation Rate
Figure 3.13: Forecast for the Global Unemployment Rate
Figure 3.14: Forecast for the Regional GDP Growth Rate
Figure 3.15: Forecast for the Regional Population Growth Rate
Figure 3.16: Forecast for the Regional Inflation Rate
Figure 3.17: Forecast for the Regional Unemployment Rate
Figure 3.18: Forecast for Regional Per Capita Income
Figure 3.19: Global Mevalonolactone Market by Product Type in 2019, 2024, and 2031 ($Billion)
Figure 3.20: Trends of the Global Mevalonolactone Market ($B) by Product Type (2019-2024)
Figure 3.21: Forecast for the Global Mevalonolactone Market ($B) by Product Type (2025-2031)
Figure 3.22: Trends and Forecast for Pure Mevalonolactone in the Global Mevalonolactone Market (2019-2031)
Figure 3.23: Trends and Forecast for Mevalonolactone Blends in the Global Mevalonolactone Market (2019-2031)
Figure 3.24: Trends and Forecast for Mevalonolactone Derivatives in the Global Mevalonolactone Market (2019-2031)
Figure 3.25: Global Mevalonolactone Market by Application in 2019, 2024, and 2031 ($Billion)
Figure 3.26: Trends of the Global Mevalonolactone Market ($B) by Application (2019-2024)
Figure 3.27: Forecast for the Global Mevalonolactone Market ($B) by Application (2025-2031)
Figure 3.28: Trends and Forecast for Pharmaceuticals in the Global Mevalonolactone Market (2019-2031)
Figure 3.29: Trends and Forecast for Cosmetics & Personal Care Products in the Global Mevalonolactone Market (2019-2031)
Figure 3.30: Trends and Forecast for Food & Beverage in the Global Mevalonolactone Market (2019-2031)
Figure 3.31: Trends and Forecast for Biotechnology in the Global Mevalonolactone Market (2019-2031)
Figure 3.32: Trends and Forecast for Agricultural Chemicals in the Global Mevalonolactone Market (2019-2031)
Figure 3.33: Trends and Forecast for Others in the Global Mevalonolactone Market (2019-2031)
Figure 3.34: Global Mevalonolactone Market by End Use in 2019, 2024, and 2031 ($Billion)
Figure 3.35: Trends of the Global Mevalonolactone Market ($B) by End Use (2019-2024)
Figure 3.36: Forecast for the Global Mevalonolactone Market ($B) by End Use (2025-2031)
Figure 3.37: Trends and Forecast for Pharmaceutical in the Global Mevalonolactone Market (2019-2031)
Figure 3.38: Trends and Forecast for Chemical Manufacturers in the Global Mevalonolactone Market (2019-2031)
Figure 3.39: Trends and Forecast for Food Processing in the Global Mevalonolactone Market (2019-2031)
Figure 3.40: Trends and Forecast for Biotech Firms in the Global Mevalonolactone Market (2019-2031)
Figure 3.41: Trends and Forecast for Cosmetics Manufacturers in the Global Mevalonolactone Market (2019-2031)
Figure 3.42: Trends and Forecast for Others in the Global Mevalonolactone Market (2019-2031)
Figure 4.1: Trends of the Global Mevalonolactone Market ($B) by Region (2019-2024)
Figure 4.2: Forecast for the Global Mevalonolactone Market ($B) by Region (2025-2031)
Figure 4.3: Trends and Forecast for the North American Mevalonolactone Market (2019-2031)
Figure 4.4: North American Mevalonolactone Market by Product Type in 2019, 2024, and 2031 ($Billion)
Figure 4.5: Trends of the North American Mevalonolactone Market ($B) by Product Type (2019-2024)
Figure 4.6: Forecast for the North American Mevalonolactone Market ($B) by Product Type (2025-2031)
Figure 4.7: North American Mevalonolactone Market by Application in 2019, 2024, and 2031 ($Billion)
Figure 4.8: Trends of the North American Mevalonolactone Market ($B) by Application (2019-2024)
Figure 4.9: Forecast for the North American Mevalonolactone Market ($B) by Application (2025-2031)
Figure 4.10: North American Mevalonolactone Market by End Use in 2019, 2024, and 2031 ($Billion)
Figure 4.11: Trends of the North American Mevalonolactone Market ($B) by End Use (2019-2024)
Figure 4.12: Forecast for the North American Mevalonolactone Market ($B) by End Use (2025-2031)
Figure 4.13: Trends and Forecast for the United States Mevalonolactone Market (2019-2031)
Figure 4.14: Trends and Forecast for the Mexican Mevalonolactone Market (2019-2031)
Figure 4.15: Trends and Forecast for the Canadian Mevalonolactone Market (2019-2031)
Figure 4.16: Trends and Forecast for the European Mevalonolactone Market (2019-2031)
Figure 4.17: European Mevalonolactone Market by Product Type in 2019, 2024, and 2031 ($Billion)
Figure 4.18: Trends of the European Mevalonolactone Market ($B) by Product Type (2019-2024)
Figure 4.19: Forecast for the European Mevalonolactone Market ($B) by Product Type (2025-2031)
Figure 4.20: European Mevalonolactone Market by Application in 2019, 2024, and 2031 ($Billion)
Figure 4.21: Trends of the European Mevalonolactone Market ($B) by Application (2019-2024)
Figure 4.22: Forecast for the European Mevalonolactone Market ($B) by Application (2025-2031)
Figure 4.23: European Mevalonolactone Market by End Use in 2019, 2024, and 2031 ($Billion)
Figure 4.24: Trends of the European Mevalonolactone Market ($B) by End Use (2019-2024)
Figure 4.25: Forecast for the European Mevalonolactone Market ($B) by End Use (2025-2031)
Figure 4.26: Trends and Forecast for the German Mevalonolactone Market (2019-2031)
Figure 4.27: Trends and Forecast for the French Mevalonolactone Market (2019-2031)
Figure 4.28: Trends and Forecast for the Spanish Mevalonolactone Market (2019-2031)
Figure 4.29: Trends and Forecast for the Italian Mevalonolactone Market (2019-2031)
Figure 4.30: Trends and Forecast for the United Kingdom Mevalonolactone Market (2019-2031)
Figure 4.31: Trends and Forecast for the APAC Mevalonolactone Market (2019-2031)
Figure 4.32: APAC Mevalonolactone Market by Product Type in 2019, 2024, and 2031 ($Billion)
Figure 4.33: Trends of the APAC Mevalonolactone Market ($B) by Product Type (2019-2024)
Figure 4.34: Forecast for the APAC Mevalonolactone Market ($B) by Product Type (2025-2031)
Figure 4.35: APAC Mevalonolactone Market by Application in 2019, 2024, and 2031 ($Billion)
Figure 4.36: Trends of the APAC Mevalonolactone Market ($B) by Application (2019-2024)
Figure 4.37: Forecast for the APAC Mevalonolactone Market ($B) by Application (2025-2031)
Figure 4.38: APAC Mevalonolactone Market by End Use in 2019, 2024, and 2031 ($Billion)
Figure 4.39: Trends of the APAC Mevalonolactone Market ($B) by End Use (2019-2024)
Figure 4.40: Forecast for the APAC Mevalonolactone Market ($B) by End Use (2025-2031)
Figure 4.41: Trends and Forecast for the Japanese Mevalonolactone Market (2019-2031)
Figure 4.42: Trends and Forecast for the Indian Mevalonolactone Market (2019-2031)
Figure 4.43: Trends and Forecast for the Chinese Mevalonolactone Market (2019-2031)
Figure 4.44: Trends and Forecast for the South Korean Mevalonolactone Market (2019-2031)
Figure 4.45: Trends and Forecast for the Indonesian Mevalonolactone Market (2019-2031)
Figure 4.46: Trends and Forecast for the ROW Mevalonolactone Market (2019-2031)
Figure 4.47: ROW Mevalonolactone Market by Product Type in 2019, 2024, and 2031 ($Billion)
Figure 4.48: Trends of the ROW Mevalonolactone Market ($B) by Product Type (2019-2024)
Figure 4.49: Forecast for the ROW Mevalonolactone Market ($B) by Product Type (2025-2031)
Figure 4.50: ROW Mevalonolactone Market by Application in 2019, 2024, and 2031 ($Billion)
Figure 4.51: Trends of the ROW Mevalonolactone Market ($B) by Application (2019-2024)
Figure 4.52: Forecast for the ROW Mevalonolactone Market ($B) by Application (2025-2031)
Figure 4.53: ROW Mevalonolactone Market by End Use in 2019, 2024, and 2031 ($Billion)
Figure 4.54: Trends of the ROW Mevalonolactone Market ($B) by End Use (2019-2024)
Figure 4.55: Forecast for the ROW Mevalonolactone Market ($B) by End Use (2025-2031)
Figure 4.56: Trends and Forecast for the Middle Eastern Mevalonolactone Market (2019-2031)
Figure 4.57: Trends and Forecast for the South American Mevalonolactone Market (2019-2031)
Figure 4.58: Trends and Forecast for the African Mevalonolactone Market (2019-2031)
Figure 5.1: Porter's Five Forces Analysis for the Global Mevalonolactone Market
Figure 6.1: Growth Opportunities for the Global Mevalonolactone Market by Product Type
Figure 6.2: Growth Opportunities for the Global Mevalonolactone Market by Application
Figure 6.3: Growth Opportunities for the Global Mevalonolactone Market by End Use
Figure 6.4: Growth Opportunities for the Global Mevalonolactone Market by Region
Figure 6.5: Emerging Trends in the Global Mevalonolactone Market

List of Table

Table 1.1: Growth Rate (%, 2019-2024) and CAGR (%, 2025-2031) of the Mevalonolactone Market by Product Type, Application, and End Use
Table 1.2: Attractiveness Analysis for the Mevalonolactone Market by Region
Table 1.3: Global Mevalonolactone Market Parameters and Attributes
Table 3.1: Trends of the Global Mevalonolactone Market (2019-2024)
Table 3.2: Forecast for the Global Mevalonolactone Market (2025-2031)
Table 3.3: Attractiveness Analysis for the Global Mevalonolactone Market by Product Type
Table 3.4: Market Size and CAGR of Various Product Type in the Global Mevalonolactone Market (2019-2024)
Table 3.5: Market Size and CAGR of Various Product Type in the Global Mevalonolactone Market (2025-2031)
Table 3.6: Trends of Pure Mevalonolactone in the Global Mevalonolactone Market (2019-2024)
Table 3.7: Forecast for the Pure Mevalonolactone in the Global Mevalonolactone Market (2025-2031)
Table 3.8: Trends of Mevalonolactone Blends in the Global Mevalonolactone Market (2019-2024)
Table 3.9: Forecast for the Mevalonolactone Blends in the Global Mevalonolactone Market (2025-2031)
Table 3.10: Trends of Mevalonolactone Derivatives in the Global Mevalonolactone Market (2019-2024)
Table 3.11: Forecast for the Mevalonolactone Derivatives in the Global Mevalonolactone Market (2025-2031)
Table 3.12: Attractiveness Analysis for the Global Mevalonolactone Market by Application
Table 3.13: Market Size and CAGR of Various Application in the Global Mevalonolactone Market (2019-2024)
Table 3.14: Market Size and CAGR of Various Application in the Global Mevalonolactone Market (2025-2031)
Table 3.15: Trends of Pharmaceuticals in the Global Mevalonolactone Market (2019-2024)
Table 3.16: Forecast for the Pharmaceuticals in the Global Mevalonolactone Market (2025-2031)
Table 3.17: Trends of Cosmetics & Personal Care Products in the Global Mevalonolactone Market (2019-2024)
Table 3.18: Forecast for the Cosmetics & Personal Care Products in the Global Mevalonolactone Market (2025-2031)
Table 3.19: Trends of Food & Beverage in the Global Mevalonolactone Market (2019-2024)
Table 3.20: Forecast for the Food & Beverage in the Global Mevalonolactone Market (2025-2031)
Table 3.21: Trends of Biotechnology in the Global Mevalonolactone Market (2019-2024)
Table 3.22: Forecast for the Biotechnology in the Global Mevalonolactone Market (2025-2031)
Table 3.23: Trends of Agricultural Chemicals in the Global Mevalonolactone Market (2019-2024)
Table 3.24: Forecast for the Agricultural Chemicals in the Global Mevalonolactone Market (2025-2031)
Table 3.25: Trends of Others in the Global Mevalonolactone Market (2019-2024)
Table 3.26: Forecast for the Others in the Global Mevalonolactone Market (2025-2031)
Table 3.27: Attractiveness Analysis for the Global Mevalonolactone Market by End Use
Table 3.28: Market Size and CAGR of Various End Use in the Global Mevalonolactone Market (2019-2024)
Table 3.29: Market Size and CAGR of Various End Use in the Global Mevalonolactone Market (2025-2031)
Table 3.30: Trends of Pharmaceutical in the Global Mevalonolactone Market (2019-2024)
Table 3.31: Forecast for the Pharmaceutical in the Global Mevalonolactone Market (2025-2031)
Table 3.32: Trends of Chemical Manufacturers in the Global Mevalonolactone Market (2019-2024)
Table 3.33: Forecast for the Chemical Manufacturers in the Global Mevalonolactone Market (2025-2031)
Table 3.34: Trends of Food Processing in the Global Mevalonolactone Market (2019-2024)
Table 3.35: Forecast for the Food Processing in the Global Mevalonolactone Market (2025-2031)
Table 3.36: Trends of Biotech Firms in the Global Mevalonolactone Market (2019-2024)
Table 3.37: Forecast for the Biotech Firms in the Global Mevalonolactone Market (2025-2031)
Table 3.38: Trends of Cosmetics Manufacturers in the Global Mevalonolactone Market (2019-2024)
Table 3.39: Forecast for the Cosmetics Manufacturers in the Global Mevalonolactone Market (2025-2031)
Table 3.40: Trends of Others in the Global Mevalonolactone Market (2019-2024)
Table 3.41: Forecast for the Others in the Global Mevalonolactone Market (2025-2031)
Table 4.1: Market Size and CAGR of Various Regions in the Global Mevalonolactone Market (2019-2024)
Table 4.2: Market Size and CAGR of Various Regions in the Global Mevalonolactone Market (2025-2031)
Table 4.3: Trends of the North American Mevalonolactone Market (2019-2024)
Table 4.4: Forecast for the North American Mevalonolactone Market (2025-2031)
Table 4.5: Market Size and CAGR of Various Product Type in the North American Mevalonolactone Market (2019-2024)
Table 4.6: Market Size and CAGR of Various Product Type in the North American Mevalonolactone Market (2025-2031)
Table 4.7: Market Size and CAGR of Various Application in the North American Mevalonolactone Market (2019-2024)
Table 4.8: Market Size and CAGR of Various Application in the North American Mevalonolactone Market (2025-2031)
Table 4.9: Market Size and CAGR of Various End Use in the North American Mevalonolactone Market (2019-2024)
Table 4.10: Market Size and CAGR of Various End Use in the North American Mevalonolactone Market (2025-2031)
Table 4.11: Trends of the European Mevalonolactone Market (2019-2024)
Table 4.12: Forecast for the European Mevalonolactone Market (2025-2031)
Table 4.13: Market Size and CAGR of Various Product Type in the European Mevalonolactone Market (2019-2024)
Table 4.14: Market Size and CAGR of Various Product Type in the European Mevalonolactone Market (2025-2031)
Table 4.15: Market Size and CAGR of Various Application in the European Mevalonolactone Market (2019-2024)
Table 4.16: Market Size and CAGR of Various Application in the European Mevalonolactone Market (2025-2031)
Table 4.17: Market Size and CAGR of Various End Use in the European Mevalonolactone Market (2019-2024)
Table 4.18: Market Size and CAGR of Various End Use in the European Mevalonolactone Market (2025-2031)
Table 4.19: Trends of the APAC Mevalonolactone Market (2019-2024)
Table 4.20: Forecast for the APAC Mevalonolactone Market (2025-2031)
Table 4.21: Market Size and CAGR of Various Product Type in the APAC Mevalonolactone Market (2019-2024)
Table 4.22: Market Size and CAGR of Various Product Type in the APAC Mevalonolactone Market (2025-2031)
Table 4.23: Market Size and CAGR of Various Application in the APAC Mevalonolactone Market (2019-2024)
Table 4.24: Market Size and CAGR of Various Application in the APAC Mevalonolactone Market (2025-2031)
Table 4.25: Market Size and CAGR of Various End Use in the APAC Mevalonolactone Market (2019-2024)
Table 4.26: Market Size and CAGR of Various End Use in the APAC Mevalonolactone Market (2025-2031)
Table 4.27: Trends of the ROW Mevalonolactone Market (2019-2024)
Table 4.28: Forecast for the ROW Mevalonolactone Market (2025-2031)
Table 4.29: Market Size and CAGR of Various Product Type in the ROW Mevalonolactone Market (2019-2024)
Table 4.30: Market Size and CAGR of Various Product Type in the ROW Mevalonolactone Market (2025-2031)
Table 4.31: Market Size and CAGR of Various Application in the ROW Mevalonolactone Market (2019-2024)
Table 4.32: Market Size and CAGR of Various Application in the ROW Mevalonolactone Market (2025-2031)
Table 4.33: Market Size and CAGR of Various End Use in the ROW Mevalonolactone Market (2019-2024)
Table 4.34: Market Size and CAGR of Various End Use in the ROW Mevalonolactone Market (2025-2031)
Table 5.1: Market Presence of Major Players in the Global Mevalonolactone Market
Table 5.2: Operational Integration of the Global Mevalonolactone Market
Table 6.1: New Product Launch by a Major Mevalonolactone Producer (2019-2024)

The future of the global mevalonolactone market looks promising with opportunities in the pharmaceutical, cosmetic & personal care product, food & beverage, biotechnology, and agricultural chemical markets. The global mevalonolactone market is expected to grow with a CAGR of 9.5% from 2025 to 2031. The major drivers for this market are the increasing demand for cholesterol-lowering agents, the rising need for metabolic disease treatments, and the growing focus on cardiovascular health.

Lucintel forecasts that, within the product type category, pure mevalonolactone is expected to witness the highest growth over the forecast period.
Within the application category, pharmaceutical is expected to witness the highest growth.
In terms of region, APAC is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Mevalonolactone Market

The mevalonolactone market is experiencing various emerging trends that are defining its growth and future trajectory, influenced by biotechnology advancements and growing demand for sustainable and high-purity chemicals.

Biotechnological Production Processes: A major trend is the growing investigation and utilization of biotechnological pathways to mevalonolactone synthesis. This entails biosynthesis of malonic acid through the use of genetically modified microorganisms, followed by lactonization to give mevalonolactone. Such processes hold the promise for more environmentally friendly and sustainable manufacture compared to conventional chemical synthesis.
Demand for High-Purity Mevalonolactone: There is a growing need for mevalonolactone with very high purity levels, particularly for its role as an intermediate in the synthesis of sensitive pharmaceutical chemicals and for advanced research purposes. Improvements in purification and analytical technology are essential to fulfill these stringent quality needs.
Expansion into Nutraceutical Applications: In addition to its well-established position in statin production, mevalonolactone and its derivatives are also under investigation for nutraceutical applications. Investigation into the potential benefits to health of isoprenoids produced from mevalonolactone is fueling this trend, which could provide new market segments.
Development of Novel Mevalonolactone Derivatives: Chemical modifications of mevalonolactone are resulting in the development of novel derivatives with customized properties for specific applications in the pharmaceuticals, agrochemicals, and materials science industries. This trend concentrates on broadening the application of the mevalonate platform via creative chemical synthesis.
Sustainable and Green Production Focus: The growing worldwide focus on sustainability is placing pressure on the trend to create greener and more sustainable production processes for mevalonolactone. This involves minimizing the production of waste, the use of renewable raw materials, and avoiding the use of harmful chemicals in the manufacturing process.

These new trends are collectively transforming the mevalonolactone market by increasing production innovation, improving product quality, increasing areas of application, and encouraging eco-friendliness in manufacturing processes.

Recent Developments in the Mevalonolactone Market

The recent trends in the mevalonolactone market underscore the continued activities to enhance efficiency in production, product quality, and the identification of new uses for this valuable chemical intermediate.

Optimization of Fermentation Processes: Important progress is being achieved in optimizing fermentation processes for the biotechnological manufacture of malonic acid, resulting in increased yields and reduced costs of production of mevalonolactone.
Development of Advanced Purification Technologies: Advanced purification technologies, including advanced chromatography and membrane separation technology, are being used to obtain greater levels of purity for mevalonolactone suitable for sensitive uses.
Synthesis of Chiral Mevalonolactone Derivatives: The use of effective methodology for the synthesis of chiral mevalonolactone derivatives is enhancing its application for the production of enantiomerically pure drugs intermediates.
Development of Mevalonolactone-Based Agrochemicals: Initial investigation is looking for the possibility of using mevalonolactone derivatives as new agrochemicals like plant growth regulators and insecticides.
Formation of Strategic Partnerships: Partnerships among chemical producers, biotechnology firms, and research organizations are driving innovation in mevalonolactone manufacturing and application development.

These critical developments are influencing the mevalonolactone market by making its production more sustainable and economical, improving its quality for high-demand applications, and investigating new potential applications across various industrial sectors.

Strategic Growth Opportunities in the Mevalonolactone Market

The mevalonolactone market has a number of strategic growth opportunities across different application segments, fueled by growing demand for its downstream products and emerging new applications.

Statin Drug Synthesis: Persistent incidence of hypercholesterolemia and extensive use of statin drugs guarantee a large and consistent growth prospect for mevalonolactone as a major intermediate in their manufacture.
Production of Carotenoids for Nutraceuticals and Food Coloring: The increased use of natural carotenoids, as nutraceuticals and food coloring agents, represents a growth opportunity for mevalonolactone as a precursor to their synthesis.
Synthesis of Other Isoprenoids: The broad group of isoprenoids, with uses in fragrances, flavors, and pharmaceuticals, represents a growth opportunity for mevalonolactone as a basic building block for their synthesis.
Novel Pharmaceutical Intermediate Development: The ongoing research of new therapeutic products based on the mevalonate pathway makes mevalonolactone an important starting material in their synthesis.
Synthesis of Specialty Chemicals: Mevalonolactone's specific structure and reactivity make it a useful intermediate in the preparation of specialty chemicals for a range of industrial purposes beyond pharmaceutical and nutraceutical applications.

These strategic development prospects in statin synthesis, carotenoid manufacture, other isoprenoid synthesis, new pharmaceutical intermediates, and specialty chemical synthesis highlight the ongoing significance and potential growth of the mevalonolactone market.

Mevalonolactone Market Driver and Challenges

The mevalonolactone market is subject to a mix of drivers and challenges that govern its development and expansion within the wider chemical industry.

The factors responsible for driving the mevalonolactone market include:

1. Statin Demand: The large-scale use of statin drugs for cholesterol control is a major force behind the demand for mevalonolactone, an important intermediate in their manufacture.

2. Expansion in Nutraceuticals Market: The rising consumer demand for health and wellness is driving the demand for carotenoids and other isoprenoids utilized as nutraceuticals, thus creating the demand for mevalonolactone.

3. Biotechnology Developments: Developments in genetic engineering and fermentation technology are making biotechnological production of mevalonolactone increasingly viable and economical, creating new opportunities for supply.

4. Increased Uses of Isoprenoids: Continued research continues to identify new uses for isoprenoids across many industries, continuing to fuel demand for their critical precursors such as mevalonolactone.

5. Shifting Emphasis on Sustainable Production: Global concern for sustainability is pushing companies towards the use of more environmentally friendly production processes for chemicals such as mevalonolactone, providing them with a competitive edge over others.

Challenges in the mevalonolactone market are:

1. Raw Material Price Volatility: Instability in the prices of raw materials utilized to produce mevalonolactone may affect manufacturing costs and market stability.

2. Process Complexity of Purification: High purity levels needed for application in the pharmaceutical industry may require complex and expensive purification processes.

3. Alternative Synthesis Processes: The advent of alternative synthesis processes for downstream derivatives of mevalonolactone may lower demand for the latter.

The market for mevalonolactone is spurred by the high demand for nutraceuticals and statins, development in biotechnology, growing isoprenoid uses, and emphasis on the sustainable production. Yet, the volatility of raw material prices, the complexity of purification, competition from other routes, regulatory oversight, and scalability of biotechnological production must be mitigated in order to maintain the market growth and stability.

List of Mevalonolactone Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies mevalonolactone companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the mevalonolactone companies profiled in this report include-

ADEKA
Carbosynth Product
TLC Pharmaceutical
Rinner Group
Tocris Bioscience

Mevalonolactone Market by Segment

The study includes a forecast for the global mevalonolactone market by product type, application, end use, and region.

Mevalonolactone Market by Product Type [Value from 2019 to 2031]:

Pure Mevalonolactone
Mevalonolactone Blends
Mevalonolactone Derivatives

Mevalonolactone Market by Application [Value from 2019 to 2031]:

Pharmaceuticals
Cosmetics & Personal Care Products
Food & Beverage
Biotechnology
Agricultural Chemicals
Others

Mevalonolactone Market by Region [Value from 2019 to 2031]:

North America
Europe
Asia Pacific
The Rest of the World

Country Wise Outlook for the Mevalonolactone Market

The mevalonolactone market, though not as big as a few other chemical markets, is important because it serves as a critical intermediate for the production of many high-value compounds such as statins, carotenoids, and other isoprenoids. The recent trends focus on the advancements in sustainable production processes, new purification methods, and the increasing applications of mevalonolactone derivatives. The growing need for pharmaceuticals and nutraceuticals based on the mevalonate pathway is impacting the development of this market in various geographies. This introduction sets the stage for an examination of recent developments in the mevalonolactone market in some countries.

United States: The US market for mevalonolactone is led by the robust pharmaceutical sector, especially the manufacture of statin drugs. Recent trends involve investments in cleaner and more efficient production processes. Increasing interest also lies in using mevalonolactone derivatives in research and development for new therapeutic agents beyond cholesterol control. Regulatory interest continues to focus on high purity and quality levels for pharmaceutical intermediates.
China: China's market for mevalonolactone is growing significantly, driven by its growing pharmaceutical industry and rising production of active pharmaceutical ingredients (APIs). Recent trends involve the expansion of domestic production capacities and the enhancement of manufacturing technologies to ensure international quality standards. Increasing emphasis is also being placed on the development of cost-efficient and sustainable production pathways for mevalonolactone.
Germany: Germany's market for mevalonolactone is dominated by a large focus on research and development, especially in the field of pharmaceuticals and fine chemicals. Current trends include looking into biotechnological production routes for mevalonolactone and its analogs. There is also concentration on preparing high-purity mevalonolactone for tailored applications in research and chemical synthesis of high value.
India: India's mevalonolactone industry is expanding based on its heightened pharmaceutical production and export operations. Some of the latest trends in this regard have been the new manufacturing facilities opening and attempts being made to develop the quality and cost-effectiveness of locally made mevalonolactone. There also exists a heightened interest in applying mevalonolactone as a source material for various nutraceuticals and other specialty chemicals.
Japan: Japan's mevalonolactone market is characterized by emphasis on high-quality and innovative uses. Some recent advances include work on newer purification processes and the synthesis of new mevalonolactone derivatives for specialty applications in the pharmaceutical and materials science areas. There is also a stress on sustainable production practices and minimizing environmental loading from manufacturing processes.

Features of the Global Mevalonolactone Market

Market Size Estimates: Mevalonolactone market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Mevalonolactone market size by product type, application, end use, and region in terms of value ($B).
Regional Analysis: Mevalonolactone market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product type, application, end use, and regions for the mevalonolactone market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the mevalonolactone market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the mevalonolactone market by product type (pure mevalonolactone, mevalonolactone blends, and mevalonolactone derivatives), application (pharmaceuticals, cosmetics & personal care products, food & beverage, biotechnology, agricultural chemicals, and others), end use (pharmaceutical, chemical manufacturers, food processing, biotech firms, cosmetics manufacturers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Global Mevalonolactone Market : Market Dynamics

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: PESTLE Analysis
2.4: Patent Analysis
2.5: Regulatory Environment
2.6: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
3.2. Global Mevalonolactone Market Trends (2019-2024) and Forecast (2025-2031)
3.3: Global Mevalonolactone Market by Product Type
- 3.3.1: Pure Mevalonolactone: Trends and Forecast (2019 to 2031)
- 3.3.2: Mevalonolactone Blends: Trends and Forecast (2019 to 2031)
- 3.3.3: Mevalonolactone Derivatives: Trends and Forecast (2019 to 2031)
3.4: Global Mevalonolactone Market by Application
- 3.4.1: Pharmaceuticals: Trends and Forecast (2019 to 2031)
- 3.4.2: Cosmetics & Personal Care Products: Trends and Forecast (2019 to 2031)
- 3.4.3: Food & Beverage: Trends and Forecast (2019 to 2031)
- 3.4.4: Biotechnology: Trends and Forecast (2019 to 2031)
- 3.4.5: Agricultural Chemicals: Trends and Forecast (2019 to 2031)
- 3.4.6: Others: Trends and Forecast (2019 to 2031)
3.5: Global Mevalonolactone Market by End Use
- 3.5.1: Pharmaceutical: Trends and Forecast (2019 to 2031)
- 3.5.2: Chemical Manufacturers: Trends and Forecast (2019 to 2031)
- 3.5.3: Food Processing: Trends and Forecast (2019 to 2031)
- 3.5.4: Biotech Firms: Trends and Forecast (2019 to 2031)
- 3.5.5: Cosmetics Manufacturers: Trends and Forecast (2019 to 2031)
- 3.5.6: Others: Trends and Forecast (2019 to 2031)

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

4.1: Global Mevalonolactone Market by Region
4.2: North American Mevalonolactone Market
- 4.2.1: North American Market by Product Type: Pure Mevalonolactone, Blends, and Derivatives
- 4.2.2: North American Market by Application: Pharmaceuticals, Cosmetics & Personal Care Products, Food & Beverage, Biotechnology, Agricultural Chemicals, and Others
- 4.2.3: The United States Mevalonolactone Market
- 4.2.4: Mexican Mevalonolactone Market
- 4.2.5: Canadian Mevalonolactone Market
4.3: European Mevalonolactone Market
- 4.3.1: European Market by Product Type: Pure Mevalonolactone, Blends, and Derivatives
- 4.3.2: European Market by Application: Pharmaceuticals, Cosmetics & Personal Care Products, Food & Beverage, Biotechnology, Agricultural Chemicals, and Others
- 4.3.3: German Mevalonolactone Market
- 4.3.4: French Mevalonolactone Market
- 4.3.5: Spanish Mevalonolactone Market
- 4.3.6: Italian Mevalonolactone Market
- 4.3.7: The United Kingdom Mevalonolactone Market
4.4: APAC Mevalonolactone Market
- 4.4.1: APAC Market by Product Type: Pure Mevalonolactone, Blends, and Derivatives
- 4.4.2: APAC Market by Application: Pharmaceuticals, Cosmetics & Personal Care Products, Food & Beverage, Biotechnology, Agricultural Chemicals, and Others
- 4.4.3: Japanese Mevalonolactone Market
- 4.4.4: Indian Mevalonolactone Market
- 4.4.5: Chinese Mevalonolactone Market
- 4.4.6: South Korean Mevalonolactone Market
- 4.4.7: Indonesian Mevalonolactone Market
4.5: ROW Mevalonolactone Market
- 4.5.1: ROW Market by Product Type: Pure Mevalonolactone, Blends, and Derivatives
- 4.5.2: ROW Market by Application: Pharmaceuticals, Cosmetics & Personal Care Products, Food & Beverage, Biotechnology, Agricultural Chemicals, and Others
- 4.5.3: Middle Eastern Mevalonolactone Market
- 4.5.4: South American Mevalonolactone Market
- 4.5.5: African Mevalonolactone Market

5. Competitor Analysis

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis
- Competitive Rivalry
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Threat of Substitutes
- Threat of New Entrants

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Mevalonolactone Market by Product Type
- 6.1.2: Growth Opportunities for the Global Mevalonolactone Market by Application
- 6.1.3: Growth Opportunities for the Global Mevalonolactone Market by End Use
- 6.1.4: Growth Opportunities for the Global Mevalonolactone Market by Region
6.2: Emerging Trends in the Global Mevalonolactone Market
6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Mevalonolactone Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Mevalonolactone Market
- 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

7.1: ADEKA
- Company Overview
- Mevalonolactone Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
7.2: Carbosynth Product
- Company Overview
- Mevalonolactone Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
7.3: TLC Pharmaceutical
- Company Overview
- Mevalonolactone Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
7.4: Rinner Group
- Company Overview
- Mevalonolactone Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
7.5: Tocris Bioscience
- Company Overview
- Mevalonolactone Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing

メバロノラクトンの市場レポート：2031年までの動向、予測、競合分析

Mevalonolactone Market Report: Trends, Forecast and Competitive Analysis to 2031

目次

第1章エグゼクティブサマリー

第2章世界のメバロノラクトン市場：市場力学

第3章 2019年から2031年までの市場動向と予測分析

第4章 2019年から2031年までの地域別市場動向と予測分析

第5章競合分析

第6章成長機会と戦略分析

第7章主要企業の企業プロファイル

List of Figures

List of Table

1. Statin Demand: The large-scale use of statin drugs for cholesterol control is a major force behind the demand for mevalonolactone, an important intermediate in their manufacture.

2. Expansion in Nutraceuticals Market: The rising consumer demand for health and wellness is driving the demand for carotenoids and other isoprenoids utilized as nutraceuticals, thus creating the demand for mevalonolactone.

3. Biotechnology Developments: Developments in genetic engineering and fermentation technology are making biotechnological production of mevalonolactone increasingly viable and economical, creating new opportunities for supply.

4. Increased Uses of Isoprenoids: Continued research continues to identify new uses for isoprenoids across many industries, continuing to fuel demand for their critical precursors such as mevalonolactone.

5. Shifting Emphasis on Sustainable Production: Global concern for sustainability is pushing companies towards the use of more environmentally friendly production processes for chemicals such as mevalonolactone, providing them with a competitive edge over others.

1. Raw Material Price Volatility: Instability in the prices of raw materials utilized to produce mevalonolactone may affect manufacturing costs and market stability.

2. Process Complexity of Purification: High purity levels needed for application in the pharmaceutical industry may require complex and expensive purification processes.

3. Alternative Synthesis Processes: The advent of alternative synthesis processes for downstream derivatives of mevalonolactone may lower demand for the latter.

Mevalonolactone Market by Product Type [Value from 2019 to 2031]:

Mevalonolactone Market by Application [Value from 2019 to 2031]:

Mevalonolactone Market by Region [Value from 2019 to 2031]:

This report answers following 11 key questions:

Table of Contents

1. Executive Summary

2. Global Mevalonolactone Market : Market Dynamics

3. Market Trends and Forecast Analysis from 2019 to 2031

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

5. Competitor Analysis

6. Growth Opportunities and Strategic Analysis

7. Company Profiles of Leading Players

メバロノラクトンの市場レポート：2031年までの動向、予測、競合分析

Mevalonolactone Market Report: Trends, Forecast and Competitive Analysis to 2031

目次

第1章 エグゼクティブサマリー

第2章 世界のメバロノラクトン市場：市場力学

第3章 2019年から2031年までの市場動向と予測分析

第4章 2019年から2031年までの地域別市場動向と予測分析

第5章 競合分析

第6章 成長機会と戦略分析

第7章 主要企業の企業プロファイル

List of Figures

List of Table

1. Statin Demand: The large-scale use of statin drugs for cholesterol control is a major force behind the demand for mevalonolactone, an important intermediate in their manufacture.

2. Expansion in Nutraceuticals Market: The rising consumer demand for health and wellness is driving the demand for carotenoids and other isoprenoids utilized as nutraceuticals, thus creating the demand for mevalonolactone.

3. Biotechnology Developments: Developments in genetic engineering and fermentation technology are making biotechnological production of mevalonolactone increasingly viable and economical, creating new opportunities for supply.

4. Increased Uses of Isoprenoids: Continued research continues to identify new uses for isoprenoids across many industries, continuing to fuel demand for their critical precursors such as mevalonolactone.

5. Shifting Emphasis on Sustainable Production: Global concern for sustainability is pushing companies towards the use of more environmentally friendly production processes for chemicals such as mevalonolactone, providing them with a competitive edge over others.

1. Raw Material Price Volatility: Instability in the prices of raw materials utilized to produce mevalonolactone may affect manufacturing costs and market stability.

2. Process Complexity of Purification: High purity levels needed for application in the pharmaceutical industry may require complex and expensive purification processes.

3. Alternative Synthesis Processes: The advent of alternative synthesis processes for downstream derivatives of mevalonolactone may lower demand for the latter.

Mevalonolactone Market by Product Type [Value from 2019 to 2031]:

Mevalonolactone Market by Application [Value from 2019 to 2031]:

Mevalonolactone Market by Region [Value from 2019 to 2031]:

This report answers following 11 key questions:

Table of Contents

1. Executive Summary

2. Global Mevalonolactone Market : Market Dynamics

3. Market Trends and Forecast Analysis from 2019 to 2031

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

5. Competitor Analysis

6. Growth Opportunities and Strategic Analysis

7. Company Profiles of Leading Players

第1章エグゼクティブサマリー

第2章世界のメバロノラクトン市場：市場力学

第5章競合分析

第6章成長機会と戦略分析

第7章主要企業の企業プロファイル